Skip to Main Content

Paper Details

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study.
Diabetes Care
4
2023
CV death, DPP4i, HbA1c, Sulfonylureas, TZD, Type 2 Diabetes, diabetes, dipeptidyl peptidase 4, glucose, heart failure, ischemic stroke, metformin, myocardial infarction, people, sulfonylureas, thiazolidinediones, type 2 diabetes
Author NameAffiliation
Sarah H Wild7College of Medicine and Veterinary Medicine, University of Edinburgh
Naveed Sattar9Institute of Cardiovascular and Medical Sciences
Daniel R MoralesUniversity of Dundee
Daniel R MoralesUniversity of Dundee
  • 1 - 4

Datasets

Release 1.2